Clinical studies recruiting near Nantes

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Generation of an Artificial Intelligence Algorithm Based on the Analysis of Melanoma Peri-scar Dermatoheliosis, as a Pre
Phase N/A · Nantes University Hospital · Nantes University Hospital · NCT05856565 A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU de Nantes - Service Hématologie · The Lymphoma Academic Research Organisation · NCT07018752 Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Phase 3 · CHU de Nantes · TBF Genie Tissulaire · NCT06450470 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU de Nantes · Fondation Hôpital Saint-Joseph · NCT05674994 DVT Burden and the Risk of Post-thrombotic Syndrome
NA · Centre Hospitalier Universitaire de Nantes · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06385353 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHU Nantes · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Centre Hospitalier Universitaire de Nantes - L' Hopital l'hô · Merck Sharp & Dohme LLC · NCT07266831 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - · Miltenyi Biomedicine GmbH · NCT04844866 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerabili
Phase 1/Phase 2 · CHU de Nantes · Lumara Bio Oncologics GmbH · NCT05706129 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · CHU de Nantes - Hotel Dieu · Ichnos Sciences SA · NCT05862012 French Colorectal ESD Cohort in Experts Centers
Phase N/A · Clinique Jules Vernes · University Hospital, Limoges · NCT04592003 Metabolic Fluid Responsiveness in Children
Phase N/A · Hôpital mère-enfant - CHU de Nantes · University Hospital, Bordeaux · NCT07255469 A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · Research Site · AstraZeneca · NCT07571746 A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome S
Phase N/A · CHU Hôtel Dieu · Centre Hospitalier Universitaire Dijon · NCT06875089 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital Laennec · Hospices Civils de Lyon · NCT03593317 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Nantes University Hospital · Poitiers University Hospital · NCT05686850 Study of a Patient Cohort Following Digestive Surgical Care After the Implementation of a Telemonitoring and Tele-coordi
Phase N/A · CHU Nantes- Digestive Surgery Department · Nantes University Hospital · NCT07186738 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · CHU de Nantes - Hôpital Femme-Enfant-Adolescent · PedAL BCU, LLC · NCT05183035 Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Phase N/A · Nantes University Hospital · Nantes University Hospital · NCT06244433 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · University Hospital Laennec · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Service d'Hématologie Clinique CHU Nantes · University Hospital, Clermont-Ferrand · NCT04935684 Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
Phase 3 · CHU de Nantes · Centre Hospitalier Universitaire de Nice · NCT05902221 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Chu de Nantes · Hospices Civils de Lyon · NCT05444712 Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Phase 3 · Centre Catherine de Sienne · The Lymphoma Academic Research Organisation · NCT06006117 Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children
Phase N/A · Pediatric Surgery Service, University Hospital, Nantes · University Hospital, Tours · NCT03772119 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · CHU Nantes, Merz Investigational Site #0330068 · Merz Therapeutics GmbH · NCT07018700 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · CHU Nantes - Hotel Dieu · Janssen Research & Development, LLC · NCT07499232

Look up another city

Look up another condition